Kidney Cancer: Part 1 – Die of Cancer But Don’t Die A Bankrupt

Language: Bahasa Indonesia / Malaysia

It is bad enough to be diagnosed with metastatic kidney cancer. The situation gets more grim when you are told that there would be no cure. And you are told to take a drug that cost 100 million rupiah a month that may prolong your life from 2 months to 2 years (at most). The doctor scold you for not wanting to take the medication “because the more you wait, the more the cancer will spread and spread. You will not have any more hope”.
To offer a solution whereby the drug cost so much money is not solution to a normal wage earner. It is bad enough to get cancer but it would be even worse to make him a bankrupt while he is still alive – and perhaps leave a pile of debt that requires even his grandchildren to repay. Even if he live for an extra two years. What good is that?
On top of that, prolonging life comes with another price – severe side-effects.
So, is it really worth it?


Kidney Cancer: Part 2 – Expensive Drug That Does Not Cure



Kidney Cancer: Two Oncologsit Two Opinions

Language: English / Hokkien

LC underwent an operation to remove his right kidney. His histopathology report on 19 August, 2011 indicated: papillary renal cell carcinoma, Stage 3, paracortical lymph node with tumour metastasis. LC and his family came to CA Care again on 11 September. Listen to our conversation.

Kidney Cancer: Metastasis to Lungs

Language : English

53 years old patient with Grade 2, Renal cell carcinoma. He underwent surgery but had no other follow up treatment. 7 years down the road, cancer metastasized to his lungs.



After 7 years, his cancer metastasized to his lungs. His oncologist prescribed Sutent which cost him RM18,000 per month. However he suffered intolerable side effects. His skin yellowed. He had diarrhea. His face was swollen. He had mouth and throat sores and lost his taste. He suffered hypertenstion and hand-foot syndrome. His skin started to peel. When the dose of Sutent was reduced, he suffered similar effects. There was so much pain that he was unable to stand up and walk. He told the oncologist: I am stopping Sutent. I might die because of the drug and not because of the cancer.


Evirolimus (Afinitor)

At first Sutent shrunk tumour but the side effects on patient was intolerable. Oncologist switched to Everolimus (Afinitor) that cost RM30,000 per month, i.e. RM1,000 / tablet / day. However, patient suffered side effects: ulceration of mouth with itchiness.